Back to Gene
FGF10 gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

FGF10 gene

The FGF10 gene provides instructions for a protein essential for cell growth and the development of structures such as the ears, skeleton, and glands.

Normal Function

The FGF10 gene provides instructions for making a protein called fibroblast growth factor 10 (FGF10). This protein is part of a family of proteins called fibroblast growth factors that are involved in important processes such as cell division, regulation of cell growth and maturation, formation of blood vessels, wound healing, and development before birth. By attaching to another protein known as a receptor, the FGF10 protein triggers a cascade of chemical reactions inside the cell that signals the cell to undergo certain changes, such as maturing to take on specialized functions. During development before birth, the signals triggered by the FGF10 protein appear to stimulate cells to form the structures that make up the ears, skeleton, organs, and glands in the eyes and mouth.

Health Conditions Related to Genetic Changes

Lacrimo-auriculo-dento-digital syndrome

At least three mutations in the FGF10 gene have been found to cause lacrimo-auriculo-dento-digital (LADD) syndrome. This disorder affects the formation of the lacrimal system (the system in the eyes that produces and secretes tears), the ears, the salivary glands, the teeth, the hands, and sometimes, other parts of the body. The main features of LADD syndrome are abnormal tear production, malformed ears with hearing loss, decreased saliva production, small teeth, and hand deformities.

The FGF10 gene mutations that cause LADD syndrome reduce the amount and activity of FGF10 protein. Less growth factor is available to bind to receptors, which decreases signaling within cells. A decrease in cell signaling disrupts cell maturation and development, which results in abnormal formation of the ears, skeleton, and glands in the eyes and mouth in people with LADD syndrome.

Other disorders

Mutations in the FGF10 gene have also been found to cause a condition similar to LADD syndrome called aplasia of lacrimal and salivary glands (ALSG). Individuals with this condition have absent (aplastic) or small (hypoplastic) lacrimal glands, which secrete tears in the eyes, and aplastic or hypoplastic salivary glands. This condition often causes eye irritability, chronic tearing (epiphora), dry mouth (xerostomia), and a greater susceptibility to cavities. Sometimes, other structures that are involved in tear production are affected. The mutations that cause ALSG are thought to be less disruptive to cell signaling than the FGF10 gene mutations that cause LADD syndrome, although in rare cases, the same mutation can cause either condition.

Other Names for This Gene

  • FGF-10
  • FGF10_HUMAN
  • keratinocyte growth factor 2

Frequently Asked Questions

definitive diagnosis is made through DNA sequencing of the FGF10 gene, usually performed on a blood or saliva sample. The test looks for known pathogenic variants or novel changes that affect the protein. The sample is sent to a specialized laboratory, and results are typically available within 2–4 weeks. Genetic counseling is advised to interpret the findings and discuss inheritance.
Parents should watch for a combination of eye, ear, and oral clues: reduced tear production or dry eyes, ear abnormalities such as small or malformed ears that may affect hearing, a dry mouth or low saliva output, unusually small or missing teeth, and hand or finger deformities like shortened fingers or webbing. Early referral to a pediatrician or geneticist is recommended if several of these features appear.
Management involves a multidisciplinary team: audiologists for hearing assessments, hearing aids or cochlear implants if appropriate, and speech‑language therapy to support communication. Regular follow‑ups every 6–12 months are recommended to adjust devices and monitor speech development. Early intervention improves outcomes.
Currently, no approved gene‑replacement therapies exist for LADD. Research is exploring viral vector delivery of functional FGF10 in animal models, but clinical trials are not yet available. Patients can discuss participation in research studies through clinical trial registries or specialized centers.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA